ArticleScientific reports2025
Healthcare utilisation and economic burden of cancer on Indian households.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
India is experiencing a rising incidence of cancer with a high mortality rate at a younger age. With high catastrophic healthcare expenditures and inadequate social security, it is imperative to investigate the health-seeking behaviour and corresponding economic burden on cancer-affected households. Using a nationally representative database, we use the matching methods to analyse healthcare utilization, healthcare expenditure, and financial distress of cancer-affected households. We find that the cancer-affected households report a longer hospital stay, more surgery, medicine uptake, and diagnostic tests per member compared to non-cancer households. The out-of-pocket healthcare expenditure borne by the affected households are significantly higher and mostly inflated through inpatient care. Further, we find some adverse spill-over effect in terms of lower per-member inpatient and outpatient visits and lower healthcare expenditure for non-cancer members of affected households when they are afflicted with any diseases. The catastrophic expenditures inflict income loss and distress financing to the cancer affected households. Further, we find per-member work force participation and non-medical consumption expenditures significantly low. We also observe heterogeneous effect in terms of lower inpatient visits, lower medicine uptake, lower capability to pay for treatment, and significantly higher borrowing and selling off assets among various cancer affected socioeconomically disadvantaged groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.